A recent report showed moderate yet significant correlations between MRI tumor volume measurements 6–7 days after intratumoral oHSV treatment and percentages of tumor antigen-specific activated CD8+ T cells measured ex vivo by flow cytometry the day after MRI assessment13. The gene discussed is CD8A; the disease is neoplasm.